Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report

RATIONALE: Tumor chemotherapy could weaken the immune system of patients, which might enhance the body sensitivities to the exogenous pathogens, among which the hepatitis B virus (HBV) infection should be concerned because of the higher chances of infection and the severe outcomes, especially in Eas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Fu-Biao, Wang, Ling, Sun, Dian-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682831/
https://www.ncbi.nlm.nih.gov/pubmed/29095312
http://dx.doi.org/10.1097/MD.0000000000008518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682831/
https://www.ncbi.nlm.nih.gov/pubmed/29095312
http://dx.doi.org/10.1097/MD.0000000000008518

Ejemplares similares